WHO Lauds Iran's Research, Efforts in campaign against Coronavirus
TEHRAN (FNA)- World Health Organization (WHO) Regional Director for Eastern Mediterranean Ahmad al-Manzari praised Iran for its effective research and efforts to contain COVID-19 virus spread.
Iran’s successful approaches in the battle with COVID-19 should be shared with other states, al-Manzari said in a meeting with Iranian Health Minister Saeed Namaki in Tehran on Wednesday.
He noted that the Iranian health personnel are doing well in the fight against the epidemic.
Al-Manzari further noted that Iran is conducting research and producing vaccines to this end.
Head of Iran Food and Drug Administration (IFDA) Mohammad Reza Shanehsaz said on Wednesday that at present three coronavirus vaccines are being produced in the country, adding that the third human trial phase of one of these vaccines will complete in late spring.
“Shafa Pharmed pharmaceutical company is conducting the phase one of clinical studies of the coronavirus vaccine and it will enter phases 2 and 3 of clinical trial soon after the approval of the IFDA,” Shanehsaz, also the deputy health minister, said.
He added that the third phase of the clinical trial of the vaccine is expected to complete in late spring.
Shanehsaz also explained about the Razi Institute vaccine, noting, "The institute is working on the production of a recombinant vaccine and has succeeded in receiving the code of ethics so far, and it will start phase one of clinical trial after necessary preparations.”
“The third Iranian producer of coronavirus vaccine is Milad Darou Institute which is one of the subsidiaries of Martyr Fakhrizadeh complex and it has been active in the field of drug production for many years and is working on an inactivated virus vaccine. This institute is also in the phase of receiving the code of ethics and will soon enter the human trial phase,” he said.
Also, Namaki said on Monday that his country will in the near future stand among the biggest manufacturers of coronavirus vaccine in the world.